CMI_LatestReportOrientedBlogs

  Dry Eye Syndrome Treatment People with autoimmune disorders or other systemic ailments such as diabetes, Parkinson's disease, rosacea, rheumatoid arthritis, systemic lupus erythematosus, sarcoidosis, Sjögren syndrome, and thyroid disease are at risk for dry eye syndrome. Furthermore, dry eyes might occur as a result of difficulties with inflammation of the eyelids (blepharitis) or the surfaces of the eye. Antihistamines, antidepressants, decongestants, and blood pressure drugs, among others, can lower tear production, resulting in dry eye symptoms. According to Coherent Market Insights, The global Dry Eye Syndrome Treatment Market is estimated to be valued at US$ 5,382.6 Million in 2020 and is expected to exhibit a CAGR of 16.2% during the forecast period (2020-2027). People who spend a lot of time in front of a computer or a screen are at a higher risk of having dry eyes, since prolonged usage of a screen reduces blinking and tear production. Due to widespread use for social

  Eye Health Supplement One of the primary drivers driving the Eye Health Supplement market is the rising occurrences of vision impairment and myopic population, particularly during the COVID-19 pandemic, as a result of the increased use of screens and participation in virtual meetings while working from home. High myopia puts you at risk for a variety of degenerative eye diseases such cataracts, glaucoma, and age-related macular degeneration. The market is being driven further by an increase in demand for eye health supplements among the elderly and millennials who are prone to digital eye fatigue and myopia. The global Eye Health Supplement Market is estimated to be valued at US$ 2,258.8 million in 2020 and is expected to exhibit a CAGR of 7.7% during the forecast period (2020-2027).  According to the World Health Organization, around 2.2 billion people worldwide were diagnosed with visual impairment or blindness in 2019. Blindness rates have been found to be eight times greater i